GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biodexa Pharmaceuticals PLC (NAS:BDRX) » Definitions » Policy Acquisition Expense

BDRX (Biodexa Pharmaceuticals) Policy Acquisition Expense


View and export this data going back to 2015. Start your Free Trial

What is Biodexa Pharmaceuticals Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Biodexa Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
1 Caspian Point, Caspian Way, Cardiff, GBR, CF10 4DQ
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.